Physician
Bruyninckx, Kyle
Bruyninckx, Kyle was paid $11K by Medicaid between Mar 2021 and Jun 2022, across 23 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 47% of everything it billed.
33Billing provider infoBRUYNINCKX, KYLE
RAYVILLE, LA 71269
RAYVILLE, LA 71269
33aNPI1972770378assigned 05/14/2008
33bProvider typeInternal Medicine Physician
28Total paid$11K
24GClaims7,359
24DCodes billed23
24AFirst – last monthMar 2021 – Jun 2022
Compared with peers
Next to other Internal Medicine Physician providers in Louisiana
Rank by total paid#185 of 290
Median peer was paid$27K
This provider vs. median0.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 5,492 | $8K | |
| 2022 | 1,867 | $3K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 47% | 1,811 | 1,017 | $5K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 23% | 524 | 321 | $3K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 16% | 119 | 78 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 5.3% | 1,025 | 494 | $582.73 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.3% | 112 | 35 | $249.47 |
| 71046 | Radiologic examination, chest; 2 views | 1.4% | 110 | 64 | $159.12 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.2% | 230 | 163 | $134.13 |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.2% | 60 | 37 | $133.61 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 21 | 13 | $69.37 |
| 82962 | <1% | 978 | 517 | $54.00 | |
| 72100 | <1% | 80 | 33 | $48.98 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 683 | 410 | $44.29 |
11 more codes
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 327 | $35.33 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 38 | $24.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 424 | $19.63 |
| 81002 | <1% | 51 | $12.70 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 21 | $6.03 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 555 | $4.48 |
| 90662 | 0% | 62 | $0.00 | |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) | 0% | 21 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 58 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 19 | $0.00 |
| 82950 | 0% | 30 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.